 Adrenergic beta-Agonists
"Adrenergic beta-Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that selectively bind to and activate beta-adrenergic receptors.
| Descriptor ID |
D000318
|
| MeSH Number(s) |
D27.505.519.625.050.100.200 D27.505.696.577.050.100.200
|
| Concept/Terms |
Adrenergic beta-Agonists- Adrenergic beta-Agonists
- Adrenergic beta Agonists
- beta-Agonists, Adrenergic
- Adrenergic beta-Receptor Agonist
- Adrenergic beta Receptor Agonist
- Agonist, Adrenergic beta-Receptor
- beta-Receptor Agonist, Adrenergic
- Adrenergic beta-Receptor Agonists
- Adrenergic beta Receptor Agonists
- Agonists, Adrenergic beta-Receptor
- beta-Receptor Agonists, Adrenergic
- beta-Adrenergic Agonist
- Agonist, beta-Adrenergic
- beta Adrenergic Agonist
- Receptors Agonists, Adrenergic beta
- beta-Adrenergic Receptor Agonist
- Agonist, beta-Adrenergic Receptor
- Receptor Agonist, beta-Adrenergic
- beta Adrenergic Receptor Agonist
- beta-Adrenergic Receptor Agonists
- Agonists, beta-Adrenergic Receptor
- beta Adrenergic Receptor Agonists
- Betamimetics
- Receptor Agonists, beta-Adrenergic
- Receptor Agonists, beta Adrenergic
- Adrenergic beta-Agonist
- Adrenergic beta Agonist
- beta-Agonist, Adrenergic
- beta-Adrenergic Agonists
- Agonists, beta-Adrenergic
- beta Adrenergic Agonists
|
Below are MeSH descriptors whose meaning is more general than "Adrenergic beta-Agonists".
Below are MeSH descriptors whose meaning is more specific than "Adrenergic beta-Agonists".
This graph shows the total number of publications written about "Adrenergic beta-Agonists" by people in this website by year, and whether "Adrenergic beta-Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 0 | 1 | 1 | | 1988 | 2 | 0 | 2 | | 1992 | 0 | 1 | 1 | | 1993 | 3 | 0 | 3 | | 1994 | 2 | 0 | 2 | | 1995 | 1 | 0 | 1 | | 1996 | 2 | 0 | 2 | | 1997 | 1 | 2 | 3 | | 1998 | 2 | 1 | 3 | | 1999 | 1 | 1 | 2 | | 2000 | 1 | 1 | 2 | | 2001 | 0 | 2 | 2 | | 2002 | 2 | 0 | 2 | | 2003 | 1 | 1 | 2 | | 2004 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2006 | 1 | 2 | 3 | | 2007 | 1 | 2 | 3 | | 2008 | 1 | 0 | 1 | | 2010 | 2 | 0 | 2 | | 2011 | 0 | 4 | 4 | | 2012 | 1 | 0 | 1 | | 2013 | 0 | 2 | 2 | | 2014 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenergic beta-Agonists" by people in Profiles.
-
Baker JG, Proudman RG, Hill SJ. Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human ß1-adrenoceptor. Mol Pharmacol. 2014 May; 85(5):811-29.
-
Baker JG, Proudman RG, Hill SJ. Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human ß1-adrenoceptor. PLoS One. 2013; 8(11):e77582.
-
Xiong J, Xia M, Yi F, Abais JM, Li N, Boini KM, Li PL. Regulation of renin release via cyclic ADP-ribose-mediated signaling: evidence from mice lacking CD38 gene. Cell Physiol Biochem. 2013; 31(1):44-55.
-
Kim SJ, Zhang H, Khaliulin I, Choisy SC, Bond R, Lin H, El Haou S, Milnes JT, Hancox JC, Suleiman MS, James AF. Activation of glibenclamide-sensitive ATP-sensitive K+ channels during ß-adrenergically induced metabolic stress produces a substrate for atrial tachyarrhythmia. Circ Arrhythm Electrophysiol. 2012 Dec; 5(6):1184-92.
-
Baker JG, Adams LA, Salchow K, Mistry SN, Middleton RJ, Hill SJ, Kellam B. Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human ß-adrenoceptors. J Med Chem. 2011 Oct 13; 54(19):6874-87.
-
Bond RA, Giles H. For the love of paradox: from neurobiology to pharmacology. Behav Pharmacol. 2011 Sep; 22(5-6):385-9.
-
Baker JG, Kemp P, March J, Fretwell L, Hill SJ, Gardiner SM. Predicting in vivo cardiovascular properties of ß-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses. FASEB J. 2011 Dec; 25(12):4486-97.
-
Baker JG, Hill SJ, Summers RJ. Evolution of ß-blockers: from anti-anginal drugs to ligand-directed signalling. Trends Pharmacol Sci. 2011 Apr; 32(4):227-34.
-
Dickey BF, Walker JK, Hanania NA, Bond RA. beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol. 2010 Jun; 10(3):254-9.
-
Hanania NA, Dickey BF, Bond RA. Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism. Curr Opin Pulm Med. 2010 Jan; 16(1):1-5.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|